hUCB-MSCs分泌外体miR-21-5p通过降低TGF-β1的调节促进血管内皮尖细胞的增殖和迁移
Lingjuan Du1, Guojian Li1, Jia Wan1
1Department of General Surgery III, The Affiliated Hospital of Yunnan University, Kunming, 650021, Yunnan, China.
Current stem cell research & therapy
|July 17, 2025
概括
人类带血中介质干细胞 (hUCB-MSCs) 和它们的外体促进外周动脉疾病 (PAD) 的新血管形成. 富含miR-21-5p的外基因组通过抑制TGF-β1.1. 增强内皮尖细胞功能,从而增强内皮尖细胞功能.
科学领域:
- 再生医学是一种再生医学.
- 细胞生物学 细胞生物学
- 血管生物学 血管生物学
背景情况:
- 治疗性血管生成为周围动脉疾病 (PAD) 治疗提供了一种新的策略.
- 人类带血 介质干细胞 (hUCB-MSCs) 和它们的外体显示出促进新血管化的潜力.
- 这些细胞和外体是治疗性血管生成的关键研究目标.
研究的目的:
- 研究hUCB-MSC及其外体对血管内皮尖细胞增殖和迁移的影响.
- 确定这些影响背后的关键分子机制.
主要方法:
- 培养和识别内皮尖细胞和hUCB-MSCs.
- 外体隔离和表征. 外体隔离和表征.
- 共同培养实验和与尖端细胞的外体化.
- 用于微RNA和基因表达分析的定量PCR (qPCR) (miR-21-5p,TGF-β1).
- 西方涂抹用于蛋白质分析.
- 细胞增殖 (CCK-8,EDU),迁移 (Transwell) 和细胞灭绝 (流细胞计) 的测试.
主要成果:
- hUCB-MSCs和外体显著促进尖端细胞的增殖和迁移,同时抑制细胞亡.
- 与hUCB-MSCs相比,外体显示出更高的疗效.
- 外体miR-21-5p被确定为一个关键因素,在尖端细胞中降低TGF-β1的调节.
- 增加的miR-21-5p增强了尖端细胞的增殖和迁移,并减少了亡,TGF-β1.1可以逆转这种效应.
结论:
- 由hUCB-MSC衍生的外体,特别是那些富含miR-21-5p的外体,增强了内皮尖细胞的功能.
- 这种增强通过有针对性的抑制TGF-β1.1来实现.
- 这些发现表明,hUCB-MSC外体在PAD治疗中具有有前途的治疗潜力.
更多相关视频
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:19Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K